These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12081307)

  • 1. Phenobarbitone concentrations in the hair, saliva and plasma of eight epileptic dogs.
    Dunnett M; Littleford A; Lees P
    Vet Rec; 2002 Jun; 150(23):718-24. PubMed ID: 12081307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in serum concentration of phenobarbitone in dogs receiving regular twice daily doses in relation to the times of administration.
    Monteiro R; Anderson TJ; Innocent G; Evans NP; Penderis J
    Vet Rec; 2009 Nov; 165(19):556-8. PubMed ID: 19897869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on therapy of canine epilepsy.
    Dowling PM
    Can Vet J; 1999 Aug; 40(8):595-8. PubMed ID: 12001345
    [No Abstract]   [Full Text] [Related]  

  • 4. Population pharmacokinetics of extended-release levetiracetam in epileptic dogs when administered alone, with phenobarbital or zonisamide.
    Muñana KR; Otamendi AJ; Nettifee JA; Papich MG
    J Vet Intern Med; 2018 Sep; 32(5):1677-1683. PubMed ID: 30238679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imepitoin withdrawal in dogs with idiopathic epilepsy well-controlled with imepitoin and phenobarbital and/or potassium bromide does not increase seizure frequency.
    Stee K; Martlé V; Broeckx BJG; Royaux E; Van Ham L; Bhatti SFM
    Vet J; 2017 Dec; 230():1-5. PubMed ID: 29208209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-related biochemical changes in the serum of dogs being treated with phenobarbitone.
    Aitken MM; Hall E; Scott L; Davot JL; Allen WM
    Vet Rec; 2003 Jul; 153(1):13-6. PubMed ID: 12877211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug choice and therapeutic drug monitoring in the management of canine primary epilepsy.
    Vaughan-Scott T; Taylor JH
    J S Afr Vet Assoc; 1999 Dec; 70(4):172-6. PubMed ID: 10855844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of timing of blood collection on serum phenobarbital concentrations in dogs with epilepsy.
    Levitski RE; Trepanier LA
    J Am Vet Med Assoc; 2000 Jul; 217(2):200-4. PubMed ID: 10909458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy.
    Muñana KR; Nettifee-Osborne JA; Papich MG
    J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of phenobarbital in serum, cerebrospinal fluid, and saliva in the dog.
    Skinner SF; Robertson LT; Artero M; Gerding RK
    Am J Vet Res; 1980 Apr; 41(4):600-4. PubMed ID: 7406279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy.
    Neßler J; Rundfeldt C; Löscher W; Kostic D; Keefe T; Tipold A
    BMC Vet Res; 2017 Jan; 13(1):33. PubMed ID: 28118828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epileptic seizure frequency and semiology in dogs with idiopathic epilepsy after initiation of imepitoin or phenobarbital monotherapy.
    Stabile F; van Dijk J; Barnett CR; De Risio L
    Vet J; 2019 Jul; 249():53-57. PubMed ID: 31239165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euthyroid sick syndrome in dogs with idiopathic epilepsy before treatment with anticonvulsant drugs.
    von Klopmann T; Boettcher IC; Rotermund A; Rohn K; Tipold A
    J Vet Intern Med; 2006; 20(3):516-22. PubMed ID: 16734083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of the maximal electro-shock seizure model in dogs.
    Territo PR; Freise KJ; Newhall K; Barnhart SD; Peters SC; Engleking DR; Burnett TJ; Abdul-Karim B; Shannon HE
    J Vet Pharmacol Ther; 2007 Dec; 30(6):508-15. PubMed ID: 17991218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregabalin as an adjunct to phenobarbital, potassium bromide, or a combination of phenobarbital and potassium bromide for treatment of dogs with suspected idiopathic epilepsy.
    Dewey CW; Cerda-Gonzalez S; Levine JM; Badgley BL; Ducoté JM; Silver GM; Cooper JJ; Packer RA; Lavely JA
    J Am Vet Med Assoc; 2009 Dec; 235(12):1442-9. PubMed ID: 20001779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996).
    Trepanier LA; Van Schoick A; Schwark WS; Carrillo J
    J Am Vet Med Assoc; 1998 Nov; 213(10):1449-53. PubMed ID: 9828942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic epilepsy in dogs: owners' perspectives on management with phenobarbitone and/or potassium bromide.
    Chang Y; Mellor DJ; Anderson TJ
    J Small Anim Pract; 2006 Oct; 47(10):574-81. PubMed ID: 17004949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing serum concentrations of levetiracetam in dogs with epilepsy.
    Saint-Maxent M; Juette T; Parent J; Castel A; Parmentier T
    J Vet Intern Med; 2024; 38(4):2249-2256. PubMed ID: 38888491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenobarbitone-induced haematological abnormalities in idiopathic epileptic dogs: prevalence, risk factors, clinical presentation and outcome.
    Bersan E; Volk HA; Ros C; De Risio L
    Vet Rec; 2014 Sep; 175(10):247. PubMed ID: 24836432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin.
    Royaux E; Van Ham L; Broeckx BJ; Van Soens I; Gielen I; Deforce D; Bhatti SF
    Vet J; 2017 Feb; 220():51-54. PubMed ID: 28190495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.